MERS
World Awaits Results Of COVID-19 Drug Treatment Developed At UAB Center
In the search for a drug treatment for COVID-19, prime interest has centered on Remdesivir, a compound produced by Gilead Sciences that has its roots in a National Institutes of Health-funded center based at UAB.
UAB Leads a New Anti-Viral Drug Trial to Combat the Coronavirus
The University of Alabama at Birmingham is leading a new anti-viral drug trial in Wuhan, China to combat the coronavirus outbreak.
